Gibbs Michael Terrence
General Counsel at T2 Biosystems, Inc.
- Sold, on record
- $70k
- Dollars the filings state
- Form 4 sales
- 10
- Latest Mar 28, 2023
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- T2 Biosystems, Inc.General Counsel
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale T2 Biosystems, Inc.Plan not statedFeb 11, 2019 2019
Sold 3,005 shares at $3.36 ($10k)
Gibbs Michael Terrence, General Counsel
Sold 5% of holdings ($202k position)57,237 shares leftFiling
- 2 Form 4 sale T2 Biosystems, Inc.Plan not statedFeb 3, 2020 +357 days
Sold 3,283 shares at $0.88 ($3k)
Gibbs Michael Terrence, General Counsel
Sold 5.7% of holdings ($50k position)53,954 shares left1.2x usual sizeFiling
- 3 Form 4 sale T2 Biosystems, Inc.Plan not statedFeb 11, 2020 +8 days
Sold 3,200 shares at $0.77 ($2k)
Gibbs Michael Terrence, General Counsel
Sold 5.4% of holdings ($46k position)56,587 shares left1.1x usual sizeFiling
- 4 Form 4 sale T2 Biosystems, Inc.Plan not statedFeb 24, 2020 +13 days
Sold 5,808 shares at $0.82 ($5k)
Gibbs Michael Terrence, General Counsel
Sold 8.7% of holdings ($55k position)60,779 shares left1.9x usual sizeFiling
- 5 Form 4 sale T2 Biosystems, Inc.Plan not statedFeb 23, 2021 +365 days
Sold 7,280 shares at $2.06 ($15k)
Gibbs Michael Terrence, General Counsel
Sold 10% of holdings ($150k position)65,347 shares left2.2x usual sizeFiling
- 6 Form 4 sale T2 Biosystems, Inc.Plan not statedMar 25, 2021 +30 days
Sold 8,758 shares at $1.56 ($14k)
Gibbs Michael Terrence, General Counsel
Sold 10.7% of holdings ($128k position)73,256 shares left1.9x usual sizeFiling
- 7 Form 4 sale T2 Biosystems, Inc.UnusualFeb 28, 2023 +705 days
Sold 3,730 shares at $0.62 ($2k)
Gibbs Michael Terrence, General Counsel
Sold 36.4% of holdings ($6k position)6,517 shares leftFiling
- 8 Form 4 sale T2 Biosystems, Inc.No planMar 28, 2023 +28 days
Sold 239 shares at $0.48 ($115)
Gibbs Michael Terrence, General Counsel
No 10b5-1 planSold 3.5% of holdings ($3k position)6,612 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (10)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 28, 2023 | Apr 6, 2023 | T2 Biosystems, Inc. | General Counsel | Form 4 sale | 239 | $115 | 3.5% | No plan | SEC |
| Feb 28, 2023 | Mar 9, 2023 | T2 Biosystems, Inc. | General Counsel | Form 4 sale | 3,730 | $2k | 36.4% | Unusual | SEC |
| Mar 25, 2021 | Mar 25, 2021 | T2 Biosystems, Inc. | General Counsel | Form 4 sale | 8,758 | $14k | 10.7% | Plan not stated | SEC |
| Feb 23, 2021 | Feb 23, 2021 | T2 Biosystems, Inc. | General Counsel | Form 4 sale | 7,280 | $15k | 10.0% | Plan not stated | SEC |
| Feb 24, 2020 | Feb 25, 2020 | T2 Biosystems, Inc. | General Counsel | Form 4 sale | 5,808 | $5k | 8.7% | Plan not stated | SEC |
| Feb 11, 2020 | Feb 12, 2020 | T2 Biosystems, Inc. | General Counsel | Form 4 sale | 3,200 | $2k | 5.4% | Plan not stated | SEC |
| Feb 3, 2020 | Feb 5, 2020 | T2 Biosystems, Inc. | General Counsel | Form 4 sale | 3,283 | $3k | 5.7% | Plan not stated | SEC |
| Feb 11, 2019 | Feb 12, 2019 | T2 Biosystems, Inc. | General Counsel | Form 4 sale | 3,005 | $10k | 5.0% | Plan not stated | SEC |
| Feb 1, 2019 | Feb 5, 2019 | T2 Biosystems, Inc. | General Counsel | Form 4 sale | 2,759 | $9k | 4.8% | Plan not stated | SEC |
| Feb 9, 2018 | Jun 8, 2018 | T2 Biosystems, Inc. | General Counsel | Form 4 sale | 2,202 | $9k | 11.5% | Plan not stated | SEC |